Greenwich LifeSciences Inc (GLSI)
14.12
+0.31
(+2.24%)
USD |
NASDAQ |
May 03, 12:05
Greenwich LifeSciences Price to Book Value: 27.14 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 26.54 |
| May 01, 2024 | 26.91 |
| April 30, 2024 | 23.87 |
| April 29, 2024 | 24.22 |
| April 26, 2024 | 25.22 |
| April 25, 2024 | 23.72 |
| April 24, 2024 | 24.26 |
| April 23, 2024 | 25.26 |
| April 22, 2024 | 24.39 |
| April 19, 2024 | 23.20 |
| April 18, 2024 | 24.78 |
| April 17, 2024 | 25.08 |
| April 16, 2024 | 27.72 |
| April 15, 2024 | 27.41 |
| April 12, 2024 | 30.08 |
| April 11, 2024 | 30.87 |
| April 10, 2024 | 30.43 |
| April 09, 2024 | 31.89 |
| April 08, 2024 | 31.54 |
| April 05, 2024 | 33.33 |
| April 04, 2024 | 34.42 |
| April 03, 2024 | 33.98 |
| April 02, 2024 | 33.54 |
| April 01, 2024 | 36.51 |
| March 28, 2024 | 38.24 |
| Date | Value |
|---|---|
| March 27, 2024 | 38.35 |
| March 26, 2024 | 38.96 |
| March 25, 2024 | 37.30 |
| March 22, 2024 | 37.62 |
| March 21, 2024 | 36.28 |
| March 20, 2024 | 35.24 |
| March 19, 2024 | 32.50 |
| March 18, 2024 | 32.66 |
| March 15, 2024 | 33.56 |
| March 14, 2024 | 31.66 |
| March 13, 2024 | 34.90 |
| March 12, 2024 | 36.68 |
| March 11, 2024 | 33.90 |
| March 08, 2024 | 29.43 |
| March 07, 2024 | 31.62 |
| March 06, 2024 | 26.37 |
| March 05, 2024 | 24.10 |
| March 04, 2024 | 24.85 |
| March 01, 2024 | 24.93 |
| February 29, 2024 | 23.32 |
| February 28, 2024 | 23.16 |
| February 27, 2024 | 23.97 |
| February 26, 2024 | 23.16 |
| February 23, 2024 | 24.79 |
| February 22, 2024 | 25.69 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.757
Minimum
Jun 16 2022
186.35
Maximum
Dec 10 2020
15.68
Average
13.13
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.68 |
| QuidelOrtho Corp | 0.5674 |
| Outlook Therapeutics Inc | -- |
| Gain Therapeutics Inc | 3.752 |
| CEL-SCI Corp | 7.233 |
Price to Book Value Related Metrics
| Price | 14.12 |
| Earnings Yield | -4.96% |
| Market Cap | 181.84M |